We are live on ! Find out more
CC

Colrain Capital Portfolio holdings

AUM $259M
1-Year Est. Return 63.6%
This Fund
S&P 500
This Quarter Est. Return
+0.48%
1 Year Est. Return
+63.6%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.14B
AUM Growth
-$64.4M
Cap. Flow
-$67M
Cap. Flow %
-5.9%
Top 10 Hldgs %
37.98%
Holding
98
New
9
Increased
18
Reduced
57
Closed
9

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$14.8M
2
GM icon
General Motors
GM
+$4.52M
3
HES
Hess
HES
+$3.93M
4
BA icon
Boeing
BA
+$3.34M
5
UAL icon
United Airlines
UAL
+$3.03M

Top Sells

Rank Stock Value
1
VTRS icon
Viatris
VTRS
+$10.3M
2
CMCSA icon
Comcast
CMCSA
+$9.19M
3
T icon
AT&T
T
+$7.11M
4
KR icon
Kroger
KR
+$5.44M
5
ESRX
Express Scripts Holding Company
ESRX
+$5.08M

Sector Composition

Rank Sector Weight
1 Healthcare 19.16%
2 Financials 15.68%
3 Technology 14.82%
4 Communication Services 11.33%
5 Industrials 11.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OCR
26
DELISTED
OMNICARE INC
OCR
$17.2M 1.52%
182,909
-41,600
-19% -$3.71M
UAL icon
27
United Airlines
UAL
$38.4B
$17.1M 1.51%
322,800
+52,300
+19% +$3.03M
AIG icon
28
American International
AIG
$41.9B
$16.9M 1.49%
273,988
-12,700
-4% -$750K
WMT icon
29
Walmart Inc
WMT
$871B
$14.5M 1.28%
612,600
-11,943
-2% -$305K
LDOS icon
30
Leidos
LDOS
$14.1B
$13.8M 1.22%
342,600
-27,687
-7% -$1.16M
APC
31
DELISTED
Anadarko Petroleum
APC
$11.4M 1%
145,941
+14,750
+11% +$1.28M
ABBV icon
32
AbbVie
ABBV
$458B
$10.8M 0.95%
160,271
-56,500
-26% -$3.69M
MET icon
33
MetLife
MET
$61B
$9.05M 0.8%
181,372
-38,148
-17% -$1.81M
MS icon
34
Morgan Stanley
MS
$337B
$8.73M 0.77%
225,000
-33,000
-13% -$1.26M
SAIC icon
35
Saic
SAIC
$5.03B
$8.56M 0.75%
162,005
-29,000
-15% -$1.51M
GG
36
DELISTED
Goldcorp Inc
GG
$8.4M 0.74%
518,500
+8,557
+2% +$156K
ABT icon
37
Abbott
ABT
$180B
$8.05M 0.71%
164,000
-15,000
-8% -$720K
SU icon
38
Suncor Energy
SU
$77.7B
$7.91M 0.7%
287,500
-126,500
-31% -$3.82M
DVN icon
39
Devon Energy
DVN
$51.9B
$7.63M 0.67%
128,300
+1,500
+1% +$97K
MRK icon
40
Merck
MRK
$324B
$7.16M 0.63%
131,824
-13,624
-9% -$764K
JPM icon
41
JPMorgan Chase
JPM
$939B
$7.03M 0.62%
103,700
-14,500
-12% -$947K
BG icon
42
Bunge Global
BG
$23.6B
$6.24M 0.55%
71,086
-18,000
-20% -$1.6M
UNH icon
43
UnitedHealth
UNH
$382B
$6.14M 0.54%
50,300
-5,800
-10% -$686K
TRV icon
44
Travelers Companies
TRV
$80.8B
$5.6M 0.49%
57,953
-6,500
-10% -$666K
B
45
Barrick Mining
B
$62.2B
$5.46M 0.48%
512,200
-39,300
-7% -$479K
ETN icon
46
Eaton
ETN
$157B
$5.15M 0.45%
76,300
-200
-0.3% -$14.1K
MOS icon
47
The Mosaic Company
MOS
$7.09B
$4.45M 0.39%
95,000
-19,000
-17% -$862K
ADM icon
48
Archer Daniels Midland
ADM
$41.4B
$4.39M 0.39%
90,978
+6,000
+7% +$303K
MRSH
49
Marsh
MRSH
$86.3B
$4.3M 0.38%
75,865
-24,500
-24% -$1.42M
PNC icon
50
PNC Financial Services
PNC
$100B
$4.24M 0.37%
44,300
-7,900
-15% -$747K

Similar funds

Colrain Capital's Q2 2015 Portfolio in Review

As of Q2 2015, Colrain Capital held 98 positions worth $1.14B, down 5.4% from $1.2B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Colrain Capital withdrew a net $67M in Q2 2015, closing 9 positions and reducing 57 holdings. Its most notable exit was Lumen, an estimated $2.68M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Financials and Technology.

Against the trend, Colrain Capital opened a new position in Coca-Cola worth $1.73M.

  • Colrain Capital's largest Q2 2015 buy was Coca-Cola: 44,000 shares worth $1.73M.
  • Colrain Capital added most to Medtronic in Q2 2015, an estimated $14.8M increase.
  • Colrain Capital's biggest Q2 2015 reduction was Viatris, cutting an estimated $10.3M.
  • Colrain Capital fully exited Lumen in Q2 2015, selling an estimated $2.68M.
  • Colrain Capital's ten largest holdings make up 38% of its $1.14B portfolio in Q2 2015.
  • Colrain Capital opened 9 new positions and closed 9 in Q2 2015.
  • Colrain Capital's portfolio value fell 5.4% quarter-over-quarter to $1.14B.

Based on Colrain Capital's 13F filing for Q2 2015, filed 11 Aug 2015.